Research Article
Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity
Table 7
Glucose-dependent insulinotropic polypeptide level changes after 24 weeks of treatment in different groups depending on BMI reduction.
|